- NEWS AND VIEWS
AI finds microbial signatures in tumours and blood across cancer types
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 579, 502-503 (2020)
doi: https://doi.org/10.1038/d41586-020-00637-w
References
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V. & Wargo, J. A. Nature Med. 25, 377–388 (2019).
Dejea, C. M. et al. Proc. Natl Acad. Sci. USA 111, 18321–18326 (2014).
Kostic, A. D. et al. Cell Host Microbe 14, 207–215 (2013).
Marshall, B. J. & Warren, J. R. Lancet 323, 1311–1315 (1984).
Bullman, S. et al. Science 358, 1443–1448 (2017).
Robinson, K. M., Crabtree, J., Mattick, J. S. A., Anderson, K. E. & Dunning Hotopp, J. C. Microbiome 5, 9 (2017).
Nakatsuji, T. et al. Nature Commun. 4, 1431 (2013).
Whittle, E., Leonard, M. O., Harrison, R., Gant, T. W. & Tonge, D. P. Front. Microbiol. 9, 3266 (2018).
Poore, G. D. et al. Nature 579, 567–574 (2020).
Geller, L. T. et al. Science 357, 1156–1160 (2017).
Riquelme, E. et al. Cell 178, 795–806 (2019).
Sethi, V. et al. Gastroenterology 155, 33–37 (2018).
Wilson, B. E., Routy, B., Nagrial, A. & Chin, V. T. Cancer Immunol. Immunother. 69, 343–354 (2020).
Competing Interests
J.A.W. is an inventor on a US patent application (PCT/US17/53.717) submitted by the University of Texas MD Anderson Cancer Center that covers methods to enhance immune checkpoint blockade responses by modulating the microbiome. J.A.W. reports compensation for speaker’s bureau and honoraria from Imedex, Dava Oncology, Omniprex, Illumina, Gilead, PeerView, Physician Education Resource, MedImmune, Exelixis, and Bristol-Myers Squibb. J.A.W. serves as a consultant / advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Merck, Biothera Pharmaceuticals and Microbiome DX. J.A.W. also receives research support from GlaxoSmithKline, Roche/Genentech, Bristol-Myers Squibb, and Novartis.